Literature DB >> 28111791

Association Between Juvenile Myelomonocytic Leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.

Samuel Paulus1, Sandra Koronowska1, Regina Fölster-Holst1.   

Abstract

The occurrence of juvenile myelomonocytic leukemia (JMML), juvenile xanthogranuloma (JXG), and neurofibromatosis type 1 (NF1) together is relatively rare. Approximately only 20 cases have been reported in the literature. It is debated whether children with NF1 and JXG are at higher risk of developing JMML than children with NF1 alone. We present the case of a boy primarily diagnosed with NF1 with coexisting JXG who developed JMML at the age of 22 months. The clinical course from initial presentation to final diagnosis is detailed and the genetic features and hematologic characteristics are discussed. We report this case to underscore the importance of close monitoring of blood count and strict clinical follow-up in children presenting with concurrent NF1 and JXG and provide a possible explanation for this association.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28111791     DOI: 10.1111/pde.13064

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  10 in total

Review 1.  [Facial manifestations of granulomatous diseases].

Authors:  F Butsch
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

2.  Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma.

Authors:  William A Lambert; Joseph A DiGiuseppe; Tatiana Lara-Ospina; Markus J Bookland; Jonathan E Martin; David S Hersh
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

3.  Mice expressing KrasG12D in hematopoietic multipotent progenitor cells develop neonatal myeloid leukemia.

Authors:  Stefan P Tarnawsky; Michihiro Kobayashi; Rebecca J Chan; Mervin C Yoder
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

Review 4.  [Granulomatous dermatoses].

Authors:  Maria Kinberger; Hanna Bonnekoh; Amrei Dilling; Katharina Meier
Journal:  Z Rheumatol       Date:  2022-07-19       Impact factor: 1.530

Review 5.  [Skin biopsy of inflammatory skin diseases in childhood-when is it reasonable?]

Authors:  A Böer-Auer; R Fölster-Holst
Journal:  Hautarzt       Date:  2018-07       Impact factor: 0.751

6.  Multiple Xanthogranulomas in an Adult Patient with Myelodysplastic Syndrome.

Authors:  Marta Martínez-García; Nicolás Silvestre-Torner; Antonio Aguilar-Martínez; Fernando Burgos-Lázaro
Journal:  Case Rep Dermatol Med       Date:  2020-12-07

7.  Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.

Authors:  Thomas Foiadelli; Matteo Naso; Amelia Licari; Alessandro Orsini; Mariasole Magistrali; Chiara Trabatti; Sabino Luzzi; Mario Mosconi; Salvatore Savasta; Gian Luigi Marseglia
Journal:  Acta Biomed       Date:  2020-06-30

8.  Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2021-04-02

9.  Disseminated juvenile xanthogranulomas with ocular involvement: A case report and literature review.

Authors:  Nadine Sophie Maalouf; Akli Aouane; Patrick Hamel; Sara-Élizabeth Jean; Myrna Chababi-Atallah; Carolina Lucena Fernandes
Journal:  SAGE Open Med Case Rep       Date:  2022-08-11

Review 10.  Neurofibromatosis in Children: Actually and Perspectives.

Authors:  Maria Lucia Sur; Ionel Armat; Genel Sur; Diana-Cristina Pop; Gabriel Samasca; Iulia Lupan; Teodora-Larisa Timis; Ioan-Alexandru Florian; Daniel Sur
Journal:  Children (Basel)       Date:  2022-01-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.